These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3937061

  • 1. Alteration of the inhibitory effect of metyrapone by reduction to metyrapol during the metabolism of methacetin in vivo in mice.
    Maser E, Legrum W.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):283-9. PubMed ID: 3937061
    [Abstract] [Full Text] [Related]

  • 2. Stereoselective reductive metabolism of metyrapone and inhibitory activity of metyrapone metabolites, metyrapol enantiomers, on steroid 11 beta-hydroxylase in the rat.
    Nagamine S, Horisaka E, Fukuyama Y, Maetani K, Matsuzawa R, Iwakawa S, Asada S.
    Biol Pharm Bull; 1997 Feb; 20(2):188-92. PubMed ID: 9057984
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis of N-oxide derivatives of metyrapone and their detection as in vitro metabolites.
    Crooks PA, Damani LA, Cowan DA.
    J Pharm Pharmacol; 1981 May; 33(5):309-12. PubMed ID: 6116779
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vanadium inhibits oxidative drug demethylation in vivo in mice.
    Heide M, Legrum W, Netter KJ, Fuhrmann GF.
    Toxicology; 1983 Jan; 26(1):63-71. PubMed ID: 6402829
    [Abstract] [Full Text] [Related]

  • 7. Assay of metyrapone, metyrapol and the isomeric mono-N-oxides of metyrapone in biological fluids by high-performance liquid chromatography.
    Usansky JI, Damani LA.
    J Chromatogr; 1991 Feb 15; 563(2):283-98. PubMed ID: 2055992
    [Abstract] [Full Text] [Related]

  • 8. The urinary metabolic profile of metyrapone in the rat. Identification of two novel isomeric metyrapol N-oxide metabolites.
    Usansky JI, Damani LA.
    Drug Metab Dispos; 1992 Feb 15; 20(1):64-9. PubMed ID: 1346999
    [Abstract] [Full Text] [Related]

  • 9. CO2 breath tests using 14C-caffeine, 14C-methacetin and 14C-phenacetin for assessing postnatal development of monooxygenase activities in rats and marmosets.
    Krüger N, Helge H, Neubert D.
    Dev Pharmacol Ther; 1991 Feb 15; 16(3):164-75. PubMed ID: 1914790
    [Abstract] [Full Text] [Related]

  • 10. Oral pharmacokinetics and in-vitro metabolism of metyrapone in male rats.
    Murata H, Higuchi T, Otagiri M.
    J Pharm Pharmacol; 2016 Aug 15; 68(8):970-9. PubMed ID: 27265478
    [Abstract] [Full Text] [Related]

  • 11. A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.
    Thornhill DP, Steffen C, Netter KJ.
    Eur J Drug Metab Pharmacokinet; 1984 Aug 15; 9(2):161-8. PubMed ID: 6430705
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of metyrapone. III. Formation of an alpha-pyridone metabolite by rat hepatic soluble enzymes.
    Damani LA, Crooks PA, Cowan DA.
    Drug Metab Dispos; 1981 Aug 15; 9(3):270-3. PubMed ID: 6113939
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carbonyl reduction of metyrapone in human liver.
    Maser E, Gebel T, Netter KJ.
    Biochem Pharmacol; 1991 Dec 11; 42 Suppl():S93-8. PubMed ID: 1722672
    [Abstract] [Full Text] [Related]

  • 15. Reduction of hepatic tetrahydrofolate and inhibition of exhalation of 14CO2 formed from [dimethylamino-14C]aminopyrine in nitrous oxide-treated rats.
    Black KA, Virayotha V, Tephly TR.
    Hepatology; 1984 Dec 11; 4(5):871-6. PubMed ID: 6434391
    [Abstract] [Full Text] [Related]

  • 16. Effects of vanadate on intracellular reduction equivalents in mouse liver and the fate of vanadium in plasma, erythrocytes and liver.
    Bruech M, Quintanilla ME, Legrum W, Koch J, Netter KJ, Fuhrmann GF.
    Toxicology; 1984 Jun 11; 31(3-4):283-95. PubMed ID: 6564811
    [Abstract] [Full Text] [Related]

  • 17. Determination of metyrapone and the enantiomers of its chiral metabolite metyrapol in human plasma and urine using coupled achiral-chiral liquid chromatography.
    Chiarotto JA, Wainer IW.
    J Chromatogr B Biomed Appl; 1995 Mar 10; 665(1):147-54. PubMed ID: 7795785
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of prostaglandin E2 catabolism and potentiation of hepatic prostaglandin E2 action in rat hepatocytes by inhibitors of oxidative metabolism.
    Brass EP, Beyerinck RA, Garrity MJ.
    Biochem Pharmacol; 1988 Apr 01; 37(7):1343-9. PubMed ID: 3162676
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats.
    Shaw PN, Tseti J, Warburton S, Adedoyin A, Houston JB.
    Drug Metab Dispos; 1986 Apr 01; 14(2):271-6. PubMed ID: 2870906
    [Abstract] [Full Text] [Related]

  • 20. An investigation into the effect of different intakes of vitamin C on drug metabolism in Gambian men.
    Powers HJ, Whitehead J, Downes R, Dighton D, Perry M.
    Int J Vitam Nutr Res; 1991 Apr 01; 61(2):135-42. PubMed ID: 1917350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.